US Stock MarketDetailed Quotes

MYGN Myriad Genetics

Watchlist
  • 12.390
  • -0.130-1.04%
Close Jan 17 16:00 ET
  • 12.390
  • 0.0000.00%
Post 16:42 ET
1.13BMarket Cap-9.68P/E (TTM)

About Myriad Genetics Company

Myriad Genetics, Inc. engages in the discovery, development, and marketing of transformative molecular diagnostic tests. It operates through the Diagnostics and Other segments. The Diagnostics segment provides testing and collaborative development of testing that is designed to assess an individual's risk of developing a disease later in life. The Other segment offers testing products and services to the pharmaceutical, biotechnology and medical research industries, research and development, and clinical services for patients, and also includes corporate services. The company was founded by Walter A. Gilbert, Mark H. Skolnick, and Peter D. Meldrum in May 1991 and is headquartered in Salt Lake City, UT.

Company Profile

SymbolMYGN
Company NameMyriad Genetics
Listing DateOct 6, 1995
Issue Price18.00
Founded1991
CEOMr. Paul J. Diaz
MarketNASDAQ
Employees2700
Fiscal Year Ends12-31
Address322 North 2200 West
CitySalt Lake City
ProvinceUtah
CountryUnited States of America
Zip Code84116
Phone1-801-584-3600

Company Executives

  • Name
  • Position
  • Salary
  • Paul J. Diaz
  • Director, President and Chief Executive Officer
  • 12.11M
  • Samraat S. Raha
  • Chief Operating Officer
  • 5.02M
  • Mark Verratti
  • Chief Commercial Officer
  • 2.88M
  • Dale Muzzey
  • Chief Scientific Officer
  • 2.23M
  • Kevin Richard Haas
  • Chief Technology Officer
  • --
  • Scott J. Leffler
  • Chief Financial Officer
  • --
  • Shereen Solaiman
  • Chief People Officer
  • --
  • Natalie Munk
  • Chief Accounting Officer
  • --
  • Margaret Ancona
  • Senior Vice President and Chief of Staff
  • --
  • S. Louise Phanstiel
  • Chairman of the Board
  • 563.49K
  • Dr. Heiner Dreismann,PhD
  • Independent Director
  • 443.49K
  • Mark S. Davis
  • Independent Director
  • --
  • Dr. Lee N. Newcomer, M.D.
  • Independent Director
  • 447.99K
  • Dr. Daniel M. Skovronsky, M.D.
  • Independent Director
  • 433.49K
  • Rashmi Kumar
  • Independent Director
  • 433.49K
  • Colleen F. Reitan
  • Independent Director
  • 443.49K
  • Paul M. Bisaro
  • Independent Director
  • 258.48K
  • Daniel K. Spiegelman
  • Independent Director
  • 433.49K
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.